← All organizations

Anterogen Co., Ltd.

For profitWebsite ↗

Also known as: Anterogen Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 31, 2024

Timeline

2000s

Jun 1, 2000
Anterogen Co., Ltd.— Founded

Drugs by trial phase (8 distinct, 21 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (21)

NCT06539429Lead sponsorPhase 1Aug 31, 2024
NCT05157958Lead sponsorPhase 2Jan 1, 2022
NCT04497805Lead sponsorPhase 2Aug 31, 2020
NCT04569409Lead sponsorPhase 3Jul 14, 2020
NCT04612465Lead sponsorPhase 3Jan 9, 2020
NCT03754465Lead sponsorPhase 2Nov 30, 2018
NCT03370874Lead sponsorPhase 3Jul 4, 2018
NCT02579369Lead sponsorPhase 1/Phase 2Dec 8, 2015
NCT02619851Lead sponsorPhase 2Dec 1, 2015
NCT02619877Lead sponsorPhase 2Oct 1, 2015
NCT02580617Lead sponsorPhase 1Apr 1, 2015
NCT02394873Lead sponsorPhase 1Mar 1, 2015
NCT02394886Lead sponsorPhase 1Nov 1, 2014
NCT02131077Lead sponsorPhase 1/Phase 2Jan 1, 2014
NCT01440699Lead sponsorPhase 1Sep 1, 2011

Details

Founded: Seoul, KR Jun 1, 2000
Last known activity: Aug 31, 2024